American Regent Debuts Gvoke VialDx, Innovative Glucagon for Radiology
SHIRLEY, N.Y., August 27, 2025 — American Regent, Inc.® has announced the commercial launch of Gvoke VialDx™ (glucagon injection),...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Prescription, Generic, and Over-The-Counter: Drugs & Products.
SHIRLEY, N.Y., August 27, 2025 — American Regent, Inc.® has announced the commercial launch of Gvoke VialDx™ (glucagon injection),...
PharmaTher Holdings Ltd. announced FDA approval of KETARx™, its ketamine product for anesthesia and sedation, marking a significant milestone...
Mahwah, New Jersey, August 19, 2025 – Glenmark Pharmaceuticals Inc., USA is set to introduce Micafungin for Injection USP...
